EUVIMEDEUVIMED entdecken
FallberichtOpen Access

A Case Report: Diagnostic Route of a Patient with PLA2G6-Infantile Neuroaxonal Dystrophy and Familial Hyperlipidemia

Ayşenur Engin Erdal, Ahmet Cevdet Ceylan, Hamit Özyürek, Berrak Bilginer Gürbüz, Aynur Küçükçongar Yavaş, Çiğdem Seher Kasapkara

Molecular Syndromology · 13.06.2026 · 1-5

DOI: 10.1159/000552885 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Syndromology, online erschienen am 13.06.2026. Verfasst von Ayşenur Engin Erdal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Deparment of Pediatric Metabolic Diseases, Eskişehir City Hospital, Eskişehir, Turkey. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The PLA2G6 gene, located on chromosome 22, is responsible for the synthesis of phospholipase A2, an enzyme that breaks down the fatty acyl groups of phospholipids. As a result of pathogenic variants of the gene, enzyme activity is impaired and oxidative damage occurs in phospholipid membranes. Case Presentation: A 17-month-old girl presenting with complaints of delayed walking and hearing loss was evaluated for inherited metabolic disorders. Metabolic screening revealed elevated levels of C22 and C24 in the very long-chain fatty acids (VLCFAs) analysis. First of all, PEX gene testing and then whole exome sequencing (WES) did not reveal any peroxisomal or inherited metabolic disorders; however, a heterozygous pathogenic variant was identified in the LDLR gene, which may explain the patient’s elevated cholesterol levels. The patient’s brain magnetic resonance imaging revealed bilateral posterior periventricular deep white matter hyperintensities, with subsequent development of cerebellar atrophy. Whole genome sequencing analysis identified a pathogenic homozygous variant in the deep intronic region of the PLA2G6 (NM_003560.4: c.2035-926G>A) gene according to the ACMG 2015 criteria. Our patient was diagnosed with PLA2G6-infantile neuroaxonal dystrophy.

Conclusion

Hyperlipidemia is a common finding, and it can cause misleading elevations in VLCFAs. This case report highlights the importance of detailed genetic analysis in the diagnosis of such cases.

Schlagwörter

Stichwörter der Autor:innen

Cerebellar atrophyInfantile neuroaxonal dystrophyNeurodegenerationPLA2G6

Autor:innen und Institutionen

  • Deparment of Pediatric Metabolic Diseases, Eskişehir City Hospital, Eskişehir, Turkey.
  • Deparment of Medical Genetic, Ankara Bilkent City Hospital, Ankara, Turkey.
  • Deparment of Pediatric Neurology, Children's Hospital, Ankara Bilkent City Hospital, Ankara, Turkey.
  • Deparment of Pediatric Metabolic Diseases, Children's Hospital, Ankara Bilkent City Hospital, Ankara, Turkey.
  • Deparment of Pediatric Metabolic Diseases, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Turkey.

Zitieren

APA

Engin Erdal, A. E., Ceylan, A. C., Özyürek, H., Bilginer Gürbüz, B., Küçükçongar Yavaş, A., & Kasapkara, Ç. S. (2026). A Case Report: Diagnostic Route of a Patient with PLA2G6-Infantile Neuroaxonal Dystrophy and Familial Hyperlipidemia. Molecular Syndromology, 1-5. https://doi.org/10.1159/000552885

Vancouver

Engin Erdal AE, Ceylan AC, Özyürek H, Bilginer Gürbüz B, Küçükçongar Yavaş A, Kasapkara ÇS. A Case Report: Diagnostic Route of a Patient with PLA2G6-Infantile Neuroaxonal Dystrophy and Familial Hyperlipidemia. Molecular Syndromology. 2026:1-5. doi:10.1159/000552885

BibTeX
@article{EnginErdal2026,
  author = {Engin Erdal, Ayşenur and Ceylan, Ahmet Cevdet and Özyürek, Hamit and Bilginer Gürbüz, Berrak and Küçükçongar Yavaş, Aynur and Kasapkara, Çiğdem Seher},
  title = {A Case Report: Diagnostic Route of a Patient with PLA2G6-Infantile Neuroaxonal Dystrophy and Familial Hyperlipidemia},
  journal = {Molecular Syndromology},
  year = {2026},
  pages = {1--5},
  doi = {10.1159/000552885}
}
Kostenlos starten →